Caroline Seymour

Managing Editor @OncLive

[Caroline Seymour @CarolineM_Sey]

I’ve got my Hear Her pin, do you? I may not treat patients, but I’m proud to support this campaign @Florez_Lab @NarjustFlorezMD #WCLC26 #lcsm

[Caroline Seymour @CarolineM_Sey]

@OncLive @drshieldsmd @IUCancerCenter I heard you enjoy ballet! What’s your favorite ballet and/or step? 🩰

For clinical, what’s more exciting in relapsed SCLC? The possibility of introducing ADCs or CAR T-cell therapy into the relapsed setting?

[OncLive.com @OncLive]

Which lung cancer abstract(s) will have your attention at the 2026 ASCO Annual Meeting?

[OncLive.com @OncLive]

What will your focus be in lung cancer at the 2026 ASCO Annual Meeting?

[Caroline Seymour @CarolineM_Sey]

In less than two weeks I'm heading to the @SGO_org Annual Meeting on Women's Cancer to spotlight the amazing research that's being done in gynecologic oncology. 

If you're interested in sharing your research or would like to see a colleague's amplified, let's talk! #SGOAM26

[OncLive.com @OncLive]

Also featuring Dr Robert Negrin and Dr Robert Emmons @muhealth @VUMChealth @UofLBCC @TischCancer @SinaiImmunol @cityofhope @MoffittNews @StanfordMed @StanfordCancer @StanfordBMT_CT @Norton_Health @uoflmedschool

[OncLive.com @OncLive]

We're passing the phone to @CParkMD of @UofL and the guests of the @OncLive News Network: On Location at @ASH_hematology! Check back today for insights on #leusm #lymsm #mmsm and more ✨ #ASH25 @drghildebrandt @MMBaljevicMD @JoshuaBrodyMD @JavierPinillaMD https://t.co/10dbsurWZB

[Caroline Seymour @CarolineM_Sey]

In two weeks I'll be back on the road ✈️ to attend one of my favorite conferences of the year: the @myESMO Congress. 🇩🇪   

This year, I'll be working alongside @CParkMD to broadcast insights from the conference floor for @OncLive’s News Network: On Location program 🎙️ #ESMO25

[Caroline Seymour @CarolineM_Sey]

In less than 1 week I’ll be attending the @MiBAnalytics Summit where I’m looking forward to:

🔎 Learning how AI/data enhance patient outcomes.
🗣️ Connecting with experts shaping the future of community oncology.
🖊️ Highlighting collaboration across the health care industry.

[Caroline Seymour @CarolineM_Sey]

Pretty in pink! Loved connecting with Dr Taplin on the ways in which oncologists are tackling inequitable care in Boston at #NYGU. Looking forward to catching up at the next meeting! @DanaFarber @gotoPER #pcsm #gotoPER @OncLive

[OncLive.com @OncLive]

Behind the scenes with @DrSpratticus and @CarolineM_Sey at #NYGU! Thank you for sitting down with us today. #pcsm @gotoPER

[Caroline Seymour @CarolineM_Sey]

We’re kicking off day 2 of the International Lung Cancer Congress here in Huntington Beach! Keep an eye out for behind the scenes photos and videos with @edgardo_ny @TonyMok9 @KarenReckampMD @NarjustFlorezMD @LudaBazhenovaMD @HatimHusainMD #gotoPER #lcsm #ILCC

[Toni Choueiri, MD @DrChoueiri]

What to consider when designing perioeperative trials in RCC ? Great talk by Dr. Axel Bex @ucl

#KCRS23 @OncoAlert

[Toni Choueiri, MD @DrChoueiri]

Very interesting presentation by Dr. Dallos from @MSKCancerCenter about targeting IL1b in RCC
#KCRS23 @OncoAlert

[Toni Choueiri, MD @DrChoueiri]

Here Dr. ⁦@KarlSemaan⁩ mentored by ⁦@SylvanBacaLab⁩ presenting sarcomatoid RCC work! Some nice and novel CHIPSeq insights

FOSL1 sounds intriguing

⁦@kidneycan⁩ ⁦@OncoAlert⁩ #KCRS23

[Toni Choueiri, MD @DrChoueiri]

A good bunch #KCRS23 focusing on curing RCC with @kidneycan

Let us amplify!

[Caroline Seymour @CarolineM_Sey]

The first of what will hopefully be many more to come #TrentSelfie @JTrentMDPhD #ASCO23 @SylvesterCancer @OncLive

[Caroline Seymour @CarolineM_Sey]

Having a blast at #ASCO23! Thanks to everyone I’ve had the chance to speak with and looking forward to those to come. Thanks to @montypal for the pose inspiration @ShannonWestin @DrJNaidoo @marklewismd @jasonlukemd @PamelaKunzMD @maryam_lustberg @JTrentMDPhD @brian_rini @OncLive

[Caroline Seymour @CarolineM_Sey]

Always a pleasure catching up with @shilpaonc and hearing about the successes of immunotherapy in urothelial cancer. Until ASCO! #blcsm #AUA23

[OncLive.com @OncLive]

Rajkumar Previews CAR-T Updates, Elranatamab Findings in Multiple Myeloma Ahead of ASH 2022 @VincentRK @MayoCancerCare @ASH_hematology #ASH22 #mmsm https://t.co/vfIT739rJT